Observational Study to Develop Dosing Chart

NCT04227171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 534

Last updated 2020-08-07

No results posted yet for this study

Summary

To confirm the predictors based on patient specific characteristics and ovarian response and develop dosing chart when Follitrope™ PFS is administered to infertility women patients.

Conditions

  • Infertile Women Undergoing IVF or ICSI

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Eligibility

Min Age
19 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-03
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04227171 on ClinicalTrials.gov